Germany and France were bracing for new lockdowns Wednesday, as governments sought to stop the fast-rising tide of coronavirus cases that are beginning to fill European hospitals.
The uptick in virus cases has prompted the state to dedicate part of the city’s civic center as a makeshift heath care center for the ill.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average.
Purdue Pharma will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.
Several states are setting records for the number of people hospitalized and leaders scrambling to find extra beds and staff.
In the United States, no treatments are specifically approved for COVID-19, but a few have been authorized for emergency use and several more are being considered.
Many say they are still running up against attitudes on wearing masks that have hardened along political lines and a false notion that rural areas are immune to widespread infections.
The politics of the crisis are complicating treatment efforts, with some people even resisting getting tested.
Health experts have attributed the spike to the reopening of colleges and K-12 schools as well as general fatigue over wearing masks and social distancing.
Medical supply chains that span oceans and continents are the fragile lifelines between raw materials and manufacturers overseas, and health care workers on COVID-19 front lines in the U.S.